These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6179153)

  • 1. The lipid nature of a tumour-associated autoantigen from a chemically induced rat hepatoma.
    Lando P; Berzins K; Perlmann P
    Scand J Immunol; 1982 Feb; 15(2):187-93. PubMed ID: 6179153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.
    Lando P; Berzins K; Gabriel J; Larsson P; Perlmann P
    Br J Cancer; 1981 Oct; 44(4):522-31. PubMed ID: 7295508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of tumour-bearer serum to D23 hepatoma cells derived from solid tumours, ascites or in vitro cultures.
    Lando P; Gabriel J; Berzins K; Perlmann P
    Scand J Immunol; 1982 Mar; 15(3):259-66. PubMed ID: 7089487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour antigens and alloantigens. II. Lack of association of rat hepatoma-D23-specific antigen with beta 2 microglobulin.
    Bowen JG; Baldwin RW
    Int J Cancer; 1979 Jun; 23(6):833-9. PubMed ID: 89102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the immunoglobulin class of complement-dependent cytotoxic antibodies in serum of D23 hepatoma-bearing rats.
    Lando P; Gabriel J; Berzins K; Perlmann P
    Scand J Immunol; 1980; 11(3):253-60. PubMed ID: 9537053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serum.
    Baldwin RW; Bowen JG; Price MR
    Br J Cancer; 1973 Jul; 28(1):16-24. PubMed ID: 4353387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-specific complement-dependent serum cytotoxicity against a chemically induced rat hepatoma.
    Price MR; Baldwin RW
    Int J Cancer; 1977 Aug; 20(2):284-91. PubMed ID: 197028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodination of rat hepatoma-specific antigens and retention of serological reactivity.
    Hannant D; Bowen JG; Price MR; Baldwin RW
    Br J Cancer; 1980 May; 41(5):716-23. PubMed ID: 6158964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of aminoazo dye induced rat hepatoma membrane fractions retaining tumour specific antigen.
    Price MR; Baldwin RW
    Br J Cancer; 1974 Nov; 30(5):382-93. PubMed ID: 4143271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of tumour-specific antigen from the serum of rats bearing transplanted aminoazo dye-induced hepatomas.
    Bowen JG; Baldwin RW
    Transplantation; 1976 Mar; 21(3):213-9. PubMed ID: 59982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differences in the antigenic structure of chromatin from the liver and hepatoma cells in the rat].
    Nanazashvili MG; Ermekova VM; Serykh MM; Umanskiĭ SR
    Eksp Onkol; 1984; 6(3):38-42. PubMed ID: 6209092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological specificity of Novikoff hepatoma chromatin: isolation of three antigenic proteins.
    Stryjecka-Zimmer M; Schmidt WN; Briggs RC; Hnilica LS
    Int J Biochem; 1982; 14(7):591-600. PubMed ID: 7049786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement-dependent cytotoxicity against hepatoma cells mediated by IgM antibodies in serum from tumor-bearing rats.
    Lando P; Blomberg F; Raftell M; Berzins K; Perlmann P
    Scand J Immunol; 1977; 6(11):1081-92. PubMed ID: 202015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells.
    Nakatsuka K; Sugiyama H; Nakagawa Y; Takahashi H
    J Hepatol; 1999 Jun; 30(6):1119-29. PubMed ID: 10406192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatoma associated embryonic antigen in tumour-bearer serum.
    Rees RC; Price MR; Shan LP; Baldwin RW
    Transplantation; 1975 May; 19(5):424-9. PubMed ID: 168675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum factors modifying cell mediated immunity to rat hepatoma d23 correlated with tumour growth.
    Bowen JG; Robins RA; Baldwin RW
    Int J Cancer; 1975 Apr; 15(4):640-50. PubMed ID: 166943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour-related antigen specificities associated with 3-methylcholanthrene-treated rat embryo cells.
    Embleton MJ; Baldwin RW
    Int J Cancer; 1979 Jun; 23(6):840-5. PubMed ID: 89103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of syngeneic complement for revealing antibody-induced cytotoxicity against a rat hepatoma.
    Price MR; Höffken K; Baldwin RW
    Transplantation; 1979 Aug; 28(2):140-3. PubMed ID: 483360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen.
    Srivastava PK; Das MR
    Int J Cancer; 1984 Mar; 33(3):417-22. PubMed ID: 6698641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of an SV40 induced sarcoma transformation associated antigen.
    Brawn RJ; Holtz JK; Dandliker WB
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):551-65. PubMed ID: 183253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.